These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 7667401)

  • 1. Serotonin receptors: subtypes, functional responses and therapeutic relevance.
    Saxena PR
    Pharmacol Ther; 1995 May; 66(2):339-68. PubMed ID: 7667401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin dysfunction syndromes: a functional common denominator for classification of depression, anxiety, and obsessive-compulsive disorder.
    Benkert O; Wetzel H; Szegedi A
    Int Clin Psychopharmacol; 1993 Sep; 8 Suppl 1():3-14. PubMed ID: 8254151
    [No Abstract]   [Full Text] [Related]  

  • 3. Serotonin receptor subtypes: implications for psychopharmacology.
    Cowen PJ
    Br J Psychiatry Suppl; 1991 Sep; (12):7-14. PubMed ID: 1840764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
    Hoyer D; Clarke DE; Fozard JR; Hartig PR; Martin GR; Mylecharane EJ; Saxena PR; Humphrey PP
    Pharmacol Rev; 1994 Jun; 46(2):157-203. PubMed ID: 7938165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical utility of pharmacological agents that act at serotonin receptors.
    Peroutka SJ; Sleight AJ; McCarthy BG; Pierce PA; Schmidt AW; Hekmatpanah CR
    J Neuropsychiatry Clin Neurosci; 1989; 1(3):253-62. PubMed ID: 2562495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nature of 5-HT1-like receptors mediating depressor responses in vagosympathectomized rats; close resemblance to the cloned 5-ht7 receptor.
    De Vries P; Villalón CM; Heiligers JP; Saxena PR
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):90-9. PubMed ID: 9228195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonergic mechanisms and current and future psychiatric practice.
    Dubovsky SL; Thomas M
    J Clin Psychiatry; 1995; 56 Suppl 2():38-48. PubMed ID: 7844106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications].
    Moulignier A
    Rev Neurol (Paris); 1994; 150(1):3-15. PubMed ID: 7801037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irritable bowel syndrome: new agents targeting serotonin receptor subtypes.
    De Ponti F; Tonini M
    Drugs; 2001; 61(3):317-32. PubMed ID: 11293643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin receptors and therapeutics.
    Launay JM; Callebert J; Bondoux D; Loric S; Maroteaux L
    Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):327-36. PubMed ID: 7522716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of GR127935, a 5-HT(1B/D) receptor ligand, with functional 5-HT receptors.
    De Vries P; Apaydin S; Villalón CM; Heiligers JP; Saxena PR
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Apr; 355(4):423-30. PubMed ID: 9109356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-hydroxytryptamine (5-HT) receptor ligands.
    Kitson SL
    Curr Pharm Des; 2007; 13(25):2621-37. PubMed ID: 17897004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further pharmacological analysis of the orphan 5-HT receptors mediating feline vasodepressor responses: close resemblance to the 5-HT7, receptor.
    Villalón CM; Centurión D; Bravo G; De Vries P; Saxena PR; Ortiz MI
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jun; 361(6):665-71. PubMed ID: 10882042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of 5-hydroxytryptamine (5-HT) receptor subtypes influencing colonic motility in conscious dogs.
    Nagakura Y; Kamato T; Nishida A; Ito H; Yamano M; Miyata K
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):489-98. PubMed ID: 8740141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Physiopathological and therapeutic perspectives on the new serotonin receptors: the type 4 receptor].
    Lefebvre H
    Rev Med Interne; 2000 Aug; 21(8):661-3. PubMed ID: 10989490
    [No Abstract]   [Full Text] [Related]  

  • 16. A review of central 5-HT receptors and their function.
    Barnes NM; Sharp T
    Neuropharmacology; 1999 Aug; 38(8):1083-152. PubMed ID: 10462127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 5-HT1A receptor and its ligands: structure and function.
    Olivier B; Soudijn W; van Wijngaarden I
    Prog Drug Res; 1999; 52():103-65. PubMed ID: 10396127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain serotonin subsystem complexity and receptor heterogeneity: therapeutic potential of selective serotonin agonists and antagonists.
    Lesch KP; Aulakh CS; Murphy DL
    Psychopharmacol Ser; 1993; 10():52-69. PubMed ID: 8361982
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological profile of the 5-HT-induced inhibition of cardioaccelerator sympathetic outflow in pithed rats: correlation with 5-HT1 and putative 5-ht5A/5B receptors.
    Sánchez-Lopez A; Centurión D; Vázquez E; Arulmani U; Saxena PR; Villalón CM
    Br J Pharmacol; 2003 Oct; 140(4):725-35. PubMed ID: 14504136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unravelling the pharmacological profile of the canine external carotid vasodilator '5-HT1-like' receptors: coexistence of sympatho-inhibitory 5-HT1B and postjunctional 5-HT7 receptors.
    Villalón CM; Sánchez-López A; Centurión D; Saxena PR
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):73-80. PubMed ID: 11191839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.